U.S. Electrical Stock News

NasdaqGS:RAIL
NasdaqGS:RAILMachinery

FreightCar America (RAIL) Q4 Loss Tests Bullish Margin Narrative Despite TTM Profitability

FreightCar America (RAIL) closed FY 2025 with Q4 revenue of US$125.6 million and a basic EPS loss of US$0.50, alongside trailing twelve month EPS of US$1.16 on revenue of US$501.0 million. Over the past six reported quarters, quarterly revenue has ranged from US$96.3 million to US$160.5 million, while basic EPS has swung between a profit of US$1.54 and a loss of US$3.57. This sets up a story of improving profitability on a full year view but mixed quarterly execution. That level of earnings...
NYSE:NL
NYSE:NLCommercial Services

NL Industries (NL) Earnings Swing To Loss Challenges Bullish Narratives On Profitability

NL Industries (NL) closed out FY 2025 with Q4 revenue of US$37.7 million and a basic EPS loss of US$0.63, alongside net income excluding extra items of a US$31.0 million loss that puts margins firmly under pressure. The company has seen quarterly revenue move from US$38.4 million in Q4 2024 to US$37.7 million in Q4 2025, while basic EPS shifted from US$0.34 to a loss of US$0.63. That swing matters if you are focused on the trajectory of earnings power. With trailing 12 month net income...
NYSE:ADCT
NYSE:ADCTBiotechs

ADC Therapeutics (ADCT) Loss Narrowing To US$0.04 EPS Challenges Bearish Profitability Narrative

ADC Therapeutics (ADCT) closed out FY 2025 with Q4 revenue of US$23.1 million and a basic EPS loss of US$0.04, alongside net income excluding extra items of a US$6.4 million loss. The company has seen quarterly revenue move from US$16.9 million in Q4 2024 to US$23.1 million in Q4 2025, while basic EPS losses shifted from US$0.29 to US$0.04 over the same period. This sets the stage for investors to focus on how these headline figures translate into the quality and direction of margins. See our...
NYSE:PINE
NYSE:PINEREITs

Should Alpine’s New High‑Coupon Mortgage Loan Strategy Shape How Investors View PINE’s Risk Profile?

Alpine Income Property Trust, Inc. recently originated a US$32.0 million first mortgage loan, funding US$8.6 million at close, to back the development of an 11‑acre, 101,000‑square‑foot retail center with investment grade tenants and three outparcels in the Covington Town Center master plan near Atlanta. The high‑coupon, 24‑month loan tied to a Target‑anchored project adjacent to an existing Publix highlights Alpine’s growing use of higher‑yield structured financing alongside its net lease...
NasdaqCM:RLMD
NasdaqCM:RLMDPharmaceuticals

A Look At Relmada Therapeutics (RLMD) Valuation After NDV‑01 Phase 2 Bladder Cancer Data

Phase 2 NDV-01 data and what it could mean for Relmada Therapeutics (RLMD) Relmada Therapeutics (RLMD) has drawn fresh attention after reporting 12 month interim Phase 2 data for NDV-01 in high risk non muscle invasive bladder cancer, showing strong complete response rates and a favorable safety profile. See our latest analysis for Relmada Therapeutics. The NDV-01 update and recent Leerink healthcare conference appearance came alongside a sharp shift in sentiment, with Relmada Therapeutics’ 1...
OTCPK:TYFG
OTCPK:TYFGBanks

Tri-County Financial Group FY 2025 Margin Improvement Challenges Longer Term Profit Decline Narratives

Tri-County Financial Group (OTCPK:TYFG) has wrapped up FY 2025 with fourth quarter revenue of US$17.8 million and basic EPS of US$1.64, alongside trailing twelve month revenue of US$66.7 million and EPS of US$5.73 that sit against a 31% year over year earnings increase and a net profit margin of 20.5%. Over recent periods the company has seen revenue move from US$59.8 million and EPS of US$4.32 on a trailing basis in Q4 2024 to US$66.7 million and EPS of US$5.73 by Q4 2025, with margins...
NasdaqGS:BCPC
NasdaqGS:BCPCChemicals

Balchem Launches Metalosate TEAM As Valuation And Growth Expectations Converge

Balchem has launched its Metalosate T.E.A.M. digital platform, a proprietary tool for advanced plant nutrition recommendations. The platform uses decades of company research to provide data driven micronutrient guidance for specialty crops. This free resource is aimed at helping advisors and growers refine yield, quality, and input efficiency during early and in-season planning. For investors watching Balchem (NasdaqGS:BCPC), the Metalosate T.E.A.M. launch adds a fresh development in the...
NasdaqGS:DBX
NasdaqGS:DBXSoftware

Is Dropbox (DBX) Still Attractive After Recent Share Price Recovery?

If you are wondering whether Dropbox shares still offer value at around US$26.74, you are not alone. This article is here to unpack what that price could mean for long term investors. The stock has returned 2.2% over the last 7 days and 7.0% over the last 30 days, while year to date returns sit at a 0.7% decline and the 1 year return is 5.8%, with a 3 year gain of 36.7% and a 5 year return of a 3.6% decline. Recent market attention on Dropbox has focused on how the business is positioned...
NasdaqGS:ERII
NasdaqGS:ERIIMachinery

A Look At Energy Recovery (ERII) Valuation After PX Q650 Desalination Launch

Why the PX Q650 launch matters for Energy Recovery (ERII) investors Energy Recovery (ERII) has drawn fresh attention after launching its PX Q650 Pressure Exchanger for desalination, combining higher flow capacity, very high stated efficiency, and extended warranties aimed at long-life plant operations. See our latest analysis for Energy Recovery. The PX Q650 launch comes on the heels of Energy Recovery’s recent earnings update. It arrives at a time when the stock has seen a 4.81% 1 day share...
NasdaqGS:NEOG
NasdaqGS:NEOGMedical Equipment

Is Neogen (NEOG) Pricing Make Sense After Mixed Share Performance This Year

If you are trying to figure out whether Neogen's current share price makes sense, you are not alone. A closer look at its valuation tools can help you frame that question more clearly. Neogen recently closed at US$9.70, with returns of a 13% decline over 7 days, a 10.2% decline over 30 days, a 38.6% gain year to date, and a 2.8% decline over the last year. This combination gives a mixed picture of how the market is currently pricing the stock. Recent coverage around Neogen has focused on the...
NasdaqGS:ALLT
NasdaqGS:ALLTSoftware

How Investors May Respond To Allot (ALLT) Returning To Profitability With 2026 Revenue Growth Guidance

In February 2026, Allot Ltd. reported fourth-quarter 2025 sales of US$28.39 million and net income of US$2.9 million, alongside full-year 2025 sales of US$101.99 million and net income of US$3.71 million, marking a shift from a loss a year earlier. At the same time, the company guided for 2026 revenue of US$113 million to US$117 million, signaling management’s confidence in accelerating growth after its return to profitability. Next, we’ll examine how Allot’s return to profitability and...
NasdaqGS:INSG
NasdaqGS:INSGCommunications

Is Inseego's (INSG) Unified 5G Edge Strategy Deepening Its Moat or Stretching It Too Thin?

Inseego recently introduced the MiFi PRO M4 enterprise mobile router, built on its new ConnectOS software and Qualcomm’s Dragonwing MBB Gen 3 platform, while also unveiling an enhanced Inseego Subscribe SaaS BSS solution for complex enterprise and government subscriber lifecycle management. Together, these launches highlight Inseego’s push to create a unified wireless edge architecture that blends 5G hardware, cloud management, and enterprise-grade security into an integrated offering for...
NYSE:YALA
NYSE:YALAInteractive Media and Services

Assessing Yalla Group (YALA) Valuation After New US$150 Million Buyback And Q1 2026 Revenue Guidance

Why Yalla Group (YALA) is back on investors’ radar Yalla Group (YALA) has drawn fresh attention after its board approved a new share repurchase program of up to US$150 million, alongside first quarter 2026 revenue guidance that factors in the timing of Ramadan. See our latest analysis for Yalla Group. Those moves come after a period where the 1 year total shareholder return of 76.9% contrasts with a more muted 0.7% year to date share price return at US$7.11, suggesting recent momentum has...
NasdaqCM:EXAS
NasdaqCM:EXASBiotechs

Exact Sciences EHR Outreach Lifts CRC Screening And Fuels Investor Interest

Exact Sciences, Amalgam Rx and Privia Health report materially higher colorectal cancer screening rates using EHR-enabled outreach and at home noninvasive tests. The coordinated program is described as scalable and has surpassed national screening benchmarks during Colorectal Cancer Awareness Month. The initiative focuses on closing screening gaps by embedding screening prompts and workflows directly into clinical systems and patient communications. For investors watching NasdaqCM:EXAS,...
NasdaqGS:EDIT
NasdaqGS:EDITBiotechs

Editas Medicine (EDIT) Q3 Loss Improvement Tests Bearish Earnings Decline Narrative

Fresh off its FY 2025 third quarter update, Editas Medicine (EDIT) posted revenue of US$7.5 million with a basic EPS loss of US$0.28. Trailing 12 month figures show revenue of US$46.4 million and a basic EPS loss of US$2.35. Over recent quarters the company has seen revenue move from US$30.6 million in Q4 2024 to US$4.7 million in Q1 2025, US$3.6 million in Q2 2025 and US$7.5 million in Q3 2025. Basic EPS losses were US$0.55, US$0.92, US$0.63 and US$0.28 across those same periods as investors...
NasdaqGS:BLKB
NasdaqGS:BLKBSoftware

Blackbaud Bets On Agents For Good AI To Deepen Recurring Revenue

Blackbaud (NasdaqGS:BLKB) is introducing its new Agents for Good AI portfolio, focused on the social good sector. The first product, Development Agent, is already in paid early-adopter contracts ahead of general availability. The rollout signals a shift toward monetizing proprietary AI tools within Blackbaud's software suite. For you as an investor, this move sits at the intersection of software, AI and the social impact sector, where Blackbaud already has an established presence. Many SaaS...
NYSE:REXR
NYSE:REXRIndustrial REITs

Rexford Industrial Realigns Leadership As Investors Weigh Execution And Dividend Cover

Rexford Industrial Realty (NYSE:REXR) has appointed John Nahas as Chief Operating Officer. The COO appointment is tied to the previously announced CEO transition and expands leadership responsibilities across the executive team. The move reflects an internal realignment of operational oversight at the company. Rexford Industrial Realty focuses on industrial real estate, a segment closely linked to logistics, distribution, and warehouse activity. For investors, changes in who oversees daily...
NYSE:TPH
NYSE:TPHConsumer Durables

Did Soft 2025 Results and Utah Expansion Just Shift Tri Pointe Homes' (TPH) Investment Narrative?

Tri Pointe Homes, Inc. recently reported fourth-quarter 2025 revenue of US$954.59 million and net income of US$60.16 million, with full-year revenue of US$3.40 billion and net income of US$241.09 million, all lower than the prior year. A day later, the company highlighted product expansion by unveiling Aspire at Holladay Hills in Utah, its first townhome community in the state, featuring 57 units with interiors designed by Emmy-winning Bobby Berk. We’ll now examine how the weaker 2025...
NYSE:RPM
NYSE:RPMChemicals

RPM International Deal For Kalzip Raises Questions On Undervaluation

Tremco, a unit of RPM International (NYSE:RPM), has agreed to acquire Kalzip GmbH. The deal brings Kalzip’s aluminum building envelope systems into RPM’s building solutions portfolio. The acquisition is expected to expand RPM’s reach across Europe, India, and North America. RPM International, through its Tremco segment, focuses on building envelope products such as roofing, waterproofing, and related systems. Adding Kalzip’s metal roofing and façade solutions fits within that core line of...
NasdaqGS:OMDA
NasdaqGS:OMDAHealthcare

Omada Health (OMDA) Valuation Check As GAAP Profitability And GLP 1 Flex Care Launch Draw Fresh Attention

Omada Health (OMDA) is back in focus after reporting its first GAAP profitable quarter, alongside revenue growth in 2025 and improved margins, while also rolling out its GLP-1 Flex Care program for employers. See our latest analysis for Omada Health. The recent earnings beat, first GAAP profitable quarter and launch of GLP-1 Flex Care have coincided with a 20.6% 1 month share price return. However, the negative 90 day and year to date share price returns suggest momentum has only recently...
NYSE:CIVI
NYSE:CIVIOil and Gas

Assessing Civitas Resources (CIVI) Valuation After Weaker Full Year 2025 Results

Full year 2025 earnings reset the conversation Civitas Resources (CIVI) recently reported full year 2025 results, with revenue of US$4,393 million and net income of US$561 million, both lower than the prior year, putting the stock back under closer investor review. See our latest analysis for Civitas Resources. At a share price of US$27.38, Civitas Resources has seen a 5.0% decline in its 90 day share price return and a 43.4% drop in its 1 year total shareholder return. This suggests momentum...
NYSE:IOT
NYSE:IOTSoftware

US Stock Market Today: S&P 500 Futures Fall On Higher Yields And Oil Surge

The Morning Bull - US Market Morning Update Monday, Mar, 9 2026 US stock futures are pointing lower this morning, with E-mini S&P 500 contracts down about 1.3% and Nasdaq 100 futures off roughly 1.5%, as investors react to a jump in borrowing costs and energy prices. The US 10 year Treasury yield is around 4.22%, meaning mortgages, car loans, and corporate borrowing can all stay more expensive for longer, while oil above US$100 keeps pressure on fuel and transport costs. With Middle East...
NYSE:VRE
NYSE:VREResidential REITs

A Look At Veris Residential (VRE) Valuation After Recent Share Price Momentum

Recent share performance and business snapshot With no single headline event driving attention to Veris Residential (VRE), the recent share performance itself is the focus, as the stock shows double digit returns over the past month and past 3 months. Veris Residential is a real estate investment trust focused on Class A multifamily properties in the Northeast. It uses a technology enabled, vertically integrated platform to manage, operate, acquire, and develop its portfolio for residents and...